Anna Jeter
Co-founder and chief regulatory officer of AOA Dx, a women's health biotech developing an ovarian cancer blood diagnostic, and co-author of a report on women's health exits and market scalability.
Best podcasts with Anna Jeter
Ranked by the Snipd community
10 snips
Feb 27, 2026 • 32min
Women’s Health Innovation Isn’t Niche — This Report Proves It
Anna Jeter, co-founder and Chief Regulatory Officer of AOA Dx who works on early ovarian cancer detection, discusses the Women's Health Exits report. She talks about diagnostic delays, AOA Dx’s clinical progress and FDA discussions. The report’s data-driven case reframes fundraising, shows recent exit momentum, and explains how scaled exits expand access and patient impact.
Feb 1, 2026 • 14min
Why women's health is a scalable sector
Anna Jeter, co-founder and chief regulatory officer of AOA Dx and ovarian cancer diagnostic developer. She discusses a report showing women's health is scalable with $100B+ in exits and 27 unicorns. Diagnostics, especially screening and oncology, are highlighted as anchors. The conversation urges investors and entrepreneurs to see women's health as a broad, capital-efficient market with major M&A and IPO activity.
